Correcting the drug development paradigm for glioblastoma requires serial tissue sampling

Nat Med. 2023 Oct;29(10):2402-2405. doi: 10.1038/s41591-023-02464-8.

Abstract

A breakthrough in drug discovery for glioblastoma requires serial collection of tissue from the central nervous system via window of opportunity trials

MeSH terms

  • Brain Neoplasms* / drug therapy
  • Drug Development
  • Glioblastoma* / drug therapy
  • Humans